MCID: GST059
MIFTS: 30

Gestational Trophoblastic Tumor

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Gestational Trophoblastic Tumor

MalaCards integrated aliases for Gestational Trophoblastic Tumor:

Name: Gestational Trophoblastic Tumor 49 51
Gestational Trophoblastic Disease 49 69
Gestational Trophoblastic Neoplasms 69
Gestational Trophoblastic Neoplasm 49
Gtn 49

Classifications:



External Ids:

UMLS 69 C2931618

Summaries for Gestational Trophoblastic Tumor

NIH Rare Diseases : 49 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 59305Disease definitionGestational trophoblastic tumors (GTT) are malignant forms of gestational trophoblastic disease. The tumor always follows pregnancy, most often molar pregnancy (hydatidiform mole; see this term). Four histological subtypes have been described: invasive mole, gestational choriocarcinoma, placental site trophoblastic tumor and epithelioid trophoblastic tumor (see these terms).EpidemiologyExact annual incidence is not known but it is estimated to be about 1/1,000,000 women.Clinical descriptionGTTs occur following hydatidiform moles (see this term) (15% of complete moles and about 3% of partial moles), following spontaneous miscarriage (1/150) or childbirth (1/40,000). Indicative signs are an absence of normalization or a secondary elevation of total serum chorionic gonadotropin (hCG) levels after evacuation of a hydatidiform mole (more than 60% of cases), persistent unexplained metrorrhagia following spontaneous miscarriage or voluntary termination of pregnancy (VTP) (about 30% of cases) and very occasionally, unexplained metrorrhagia in the weeks or months following normal childbirth or ectopic pregnancy (about 10% of cases). Exceptionally, metastasis may be a sign of the disease in women of childbearing age.EtiologyThe etiology of gestational trophoblastic tumors is not known. Identification of a GTT is based on a total serum hCG assay, which is recommended following hydatidiform moles in patients with metrorrhagia persisting for more than six weeks after pregnancy, and in any patient of childbearing age who has metastasis (lung, liver, brain, kidney, vagina) with no known primary tumor.Diagnostic methodsDiagnosis of a post-molar GTT relies on one of the following four criteria: stable hCG levels (variation of less than 10%) with at least four weekly assays over a period of at least three weeks (days 1, 7, 14, 21), increase of at least 10% in hCG with at least three weekly assays over at least two weeks (days 1, 7, 14), persistence of detectable hCG values for more than six months following mole evacuation or based on histological diagnosis of a choriocarcinoma.Differential diagnosisGTTs must not be confused with hydatidiform moles (see this term) and, for choriocarcinomas, with non-gestational choriocarcinomas, which are most often ovarian.Management and treatmentAs soon as the diagnosis is made, staging must be performed to identify frequent metastases. Staging involves endovaginal pelvic color doppler ultrasound, pelvic and cerebral MRI, and abdominal/chest CT. A lung X-ray must be performed to calculate the FIGO 2000 score (International Federation of Obstetrics and Gynecology) in case of lung metastasis on CT. This score makes it possible to distinguish between low-risk GTTs (score of 6 or lower) and high-risk GTTs (score of 7 or higher). Management should be multidisciplinary and must be discussed by a panel of physicians in a specialized center. Low-risk tumors are treated by systemic single-agent chemotherapy, e.g. methotrexate (marketing authorization). High-risk tumors are treated first line with systemic multi-agent chemotherapy. Hysterectomy can of course not be considered for first-line treatment in women who wish to become pregnant, unless there is no option. Placental site trophoblastic tumors and epithelioid trophoblastic tumors are special cases: the FIGO score is not appropriate and total hysterectomy is the standard treatment as these tumors are usually chemo-resistant.PrognosisThe overall recovery rate is around 99%. The prognosis is very closely related to the rapidity of diagnosis, the risk level of the tumor (low or high) and the suitability of treatment.Visit the Orphanet disease page for more resources. Last updated: 3/5/2011

MalaCards based summary : Gestational Trophoblastic Tumor, also known as gestational trophoblastic disease, is related to gestational trophoblastic neoplasm and recurrent hydatidiform mole. An important gene associated with Gestational Trophoblastic Tumor is CGB5 (Chorionic Gonadotropin Beta Subunit 5). The drugs Nitroglycerin and Chorionic Gonadotropin have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and liver.

Related Diseases for Gestational Trophoblastic Tumor

Diseases related to Gestational Trophoblastic Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 19)
# Related Disease Score Top Affiliating Genes
1 gestational trophoblastic neoplasm 12.5
2 recurrent hydatidiform mole 11.2
3 hydatidiform mole, recurrent, 1 10.1
4 partial hydatidiform mole 10.1
5 pancreatic cancer 9.9
6 oral squamous cell carcinoma 9.9
7 squamous cell carcinoma 9.9
8 pancreatitis 9.9
9 paroxysmal hemicrania 9.9
10 mycobacterium tuberculosis 1 9.8
11 hepatitis 9.8
12 respiratory failure 9.8
13 arteriovenous malformation 9.8
14 vaginitis 9.8
15 pulmonary tuberculosis 9.8
16 epithelioid trophoblastic tumor 9.8
17 choriocarcinoma 9.8
18 placental site trophoblastic tumor 9.8
19 hermaphroditism 9.8

Graphical network of the top 20 diseases related to Gestational Trophoblastic Tumor:



Diseases related to Gestational Trophoblastic Tumor

Symptoms & Phenotypes for Gestational Trophoblastic Tumor

Drugs & Therapeutics for Gestational Trophoblastic Tumor

Drugs for Gestational Trophoblastic Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 169)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitroglycerin Approved, Investigational Phase 4,Phase 2 55-63-0 4510
2 Chorionic Gonadotropin Phase 4
3
Methotrexate Approved Phase 2, Phase 3 1959-05-2, 59-05-2 126941
4
Levoleucovorin Approved, Investigational Phase 2, Phase 3 68538-85-2
5
Etoposide Approved Phase 3,Phase 1 33419-42-0 36462
6
Carboplatin Approved Phase 3,Phase 1 41575-94-4 10339178 38904 498142
7
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
8
Captopril Approved Phase 3 62571-86-2 44093
9
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
10
Ribavirin Approved Phase 3 36791-04-5 37542
11
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
12
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2 22916-47-8 4189
13
Amifostine Approved, Investigational Phase 3 20537-88-6 2141
14
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
15
Palivizumab Approved, Investigational Phase 3 188039-54-5
16
Caspofungin Approved Phase 3,Phase 2 162808-62-0, 179463-17-3 2826718 468682
17
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 457193 2019
18
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
19
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
20
Cisplatin Approved Phase 3 15663-27-1 2767 441203 84093
21
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
22
Mycophenolic acid Approved Phase 3 24280-93-1 446541
23
Mycophenolate mofetil Approved, Investigational Phase 3 128794-94-5 5281078
24
Norgestimate Approved, Investigational Phase 3 35189-28-7 6540478
25
Moxifloxacin Approved, Investigational Phase 3 151096-09-2, 354812-41-2 152946
26
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
27
leucovorin Approved, Nutraceutical Phase 2, Phase 3 58-05-9 143 6006
28
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2, Phase 3 59-30-3 6037
29 Micronutrients Phase 2, Phase 3
30 Folic Acid Antagonists Phase 2, Phase 3
31 Trace Elements Phase 2, Phase 3
32 Hematinics Phase 2, Phase 3
33 Nucleic Acid Synthesis Inhibitors Phase 2, Phase 3
34 Dermatologic Agents Phase 2, Phase 3
35 Vitamin B Complex Phase 2, Phase 3
36 Vitamins Phase 2, Phase 3
37 Antidotes Phase 2, Phase 3
38 Immunosuppressive Agents Phase 2, Phase 3, Phase 1
39 Antimetabolites Phase 2, Phase 3
40 Antimetabolites, Antineoplastic Phase 2, Phase 3
41 Protective Agents Phase 2, Phase 3
42 Liver Extracts Phase 2, Phase 3, Phase 1
43 Bone Density Conservation Agents Phase 2, Phase 3
44 Antirheumatic Agents Phase 2, Phase 3
45 Calcium, Dietary Phase 2, Phase 3
46 Acyclovir Phase 3
47 valacyclovir Phase 3
48 Hydroxyitraconazole Phase 3
49 Alkylating Agents Phase 3,Phase 1
50
protease inhibitors Phase 3

Interventional clinical trials:

(show top 50) (show all 72)

# Name Status NCT ID Phase Drugs
1 Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma Unknown status NCT00294177 Phase 4
2 A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole Recruiting NCT01630954 Phase 4
3 Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms Unknown status NCT02606539 Phase 2, Phase 3 Methotrexate plus folinic acid alone
4 Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia Completed NCT00003702 Phase 3 Methotrexate
5 RCT on the Efficacy of Methotrexate for the Prevention of GTD Completed NCT01984099 Phase 3 Methotrexate;Vitamin B Complex
6 Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer Completed NCT00058071 Phase 3 amifostine trihydrate
7 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
8 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
9 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
10 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
11 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
12 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
13 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
14 Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01823315 Phase 3 MTX 1;MTX 2
15 Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01535053 Phase 3 Leucovorin Calcium;Methotrexate
16 Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor Not yet recruiting NCT02639650 Phase 3 Etoposide;actinomycin D;methotrexate;vincristine;cyclophosphamide;Paclitaxel;Cisplatin;Carboplatin
17 Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia Not yet recruiting NCT03280979 Phase 2, Phase 3 rescue regimen;high dose methotrxate
18 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
19 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3 mycophenolate mofetil;placebo
20 Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia Completed NCT00003688 Phase 2
21 A Trial for Patients With Gestational Trophoblastic Disease Completed NCT00190918 Phase 2 Pemetrexed
22 Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors Completed NCT00521118 Phase 2
23 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Completed NCT00410657 Phase 2 methylprednisolone;prednisone
24 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
25 Campath-1H + FK506 and Methylprednisolone for GVHD Completed NCT00109993 Phase 2 methylprednisolone;tacrolimus
26 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
27 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
28 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Completed NCT00064311 Phase 1, Phase 2 ravuconazole
29 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
30 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Completed NCT00795769 Phase 2 ondansetron
31 Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant Completed NCT00357084 Phase 2 methotrexate;methylprednisolone;prednisone
32 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
33 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
34 Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias Recruiting NCT03135769 Phase 2 Avelumab administration at 10mg/kg
35 Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Recruiting NCT02664961 Phase 2 TRC105;Bevacizumab
36 Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer Recruiting NCT01764802 Phase 2
37 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
38 Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy Terminated NCT00096187 Phase 2 pemetrexed disodium
39 Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload Terminated NCT01159067 Phase 2 deferasirox
40 Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Unknown status NCT00066404 Phase 1
41 Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections Unknown status NCT00769613 Phase 1
42 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
43 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Completed NCT01484015 Phase 1 cefepime hydrochloride
44 Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity Completed NCT00003548 Phase 1 aminocamptothecin colloidal dispersion
45 Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors Completed NCT00003597 Phase 1 carboplatin;etoposide;ifosfamide
46 Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant Completed NCT00569283 Phase 1
47 Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy Completed NCT00509691 Phase 1
48 Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant Completed NCT00361049 Phase 1
49 Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00957736 Phase 1
50 Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease Unknown status NCT00166790 chemotherapy agents

Search NIH Clinical Center for Gestational Trophoblastic Tumor

Genetic Tests for Gestational Trophoblastic Tumor

Anatomical Context for Gestational Trophoblastic Tumor

MalaCards organs/tissues related to Gestational Trophoblastic Tumor:

38
Bone, Bone Marrow, Liver, Brain, Kidney, Lung, Breast

Publications for Gestational Trophoblastic Tumor

Articles related to Gestational Trophoblastic Tumor:

(show top 50) (show all 59)
# Title Authors Year
1
SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor. ( 27068524 )
2016
2
BEP for high-risk gestational trophoblastic tumor: results from a cohort of 45 patients. ( 26775361 )
2015
3
Current issues in the histopathology of gestational trophoblastic tumors. ( 20055562 )
2010
4
Gestational trophoblastic tumor with liver metastasis after misoprostol abortion. ( 18762963 )
2009
5
Practical issues in the management of low-risk gestational trophoblast tumors. ( 19004403 )
2008
6
[Evaluation of treatment relating to gestational trophoblastic tumor registered to the French Trophoblastic Disease Reference Center (TDRC) in Lyon from 1999 to 2005]. ( 17336125 )
2007
7
Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor. ( 17977170 )
2007
8
Gestational trophoblastic tumor in pregnancy: a case report and review of the literature. ( 16681776 )
2006
9
Recurrent gestational trophoblastic tumor: management and risk factors for recurrence. ( 16750258 )
2006
10
Gestational trophoblastic tumor at a tertiary level cancer center: a retrospective study. ( 17165433 )
2006
11
Hepatic arteriogram for gestational trophoblastic tumor: is it useful? ( 16377586 )
2005
12
Emergency craniotomy in patients with intracranial metastatic gestational trophoblastic tumor. ( 15777896 )
2005
13
Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy. ( 15721402 )
2005
14
Salvage chemotherapy for high-risk gestational trophoblastic tumor. ( 15283050 )
2004
15
Diagnostic and prognostic significance of circulating tumor suppressor gene p53 autoantibodies in patients with gestational trophoblastic tumors. ( 15068319 )
2004
16
Floxuridine-containing regimens in the treatment of gestational trophoblastic tumor. ( 15283053 )
2004
17
Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor. ( 15305824 )
2004
18
EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. ( 15283051 )
2004
19
Management of patients with metastatic gestational trophoblastic tumor. ( 15262140 )
2004
20
[Significance of serum/cerebrospinal fluid human chorionic gonadotropin ratio and prophylactic intrathecal therapy in patients with brain metastases of gestational trophoblast tumor]. ( 14728849 )
2003
21
Angiogenin and gestational trophoblastic tumors, a promising prognostic marker. ( 12705339 )
2003
22
Correlation of risk categorization in gestational trophoblastic tumor between old and new combined staging and scoring system. ( 12696623 )
2003
23
Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor. ( 12586587 )
2003
24
Gestational trophoblastic tumor after medical abortion. ( 12738129 )
2003
25
Successful term pregnancy after selective arterial embolization of symptomatic arteriovenous malformation in the setting of gestational trophoblastic tumor. ( 12504631 )
2003
26
[18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients. ( 14529686 )
2003
27
Clinical characteristics and treatment of gestational trophoblastic tumor with vaginal metastasis. ( 11855880 )
2002
28
Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. ( 12063876 )
2002
29
Coexisting true hermaphroditism and partial hydatidiform mole developing metastatic gestational trophoblastic tumors. A case report. ( 12447683 )
2002
30
Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors. ( 12006530 )
2002
31
Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 patients. ( 11585428 )
2001
32
[Clinical study of four cases with malignant gestation trophoblastic tumor after mifepristone abortion]. ( 11286033 )
2000
33
The role of hysterectomy in the therapy of gestational trophoblastic tumor. ( 12899400 )
2000
34
CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor. ( 10710737 )
2000
35
Guidelines for the stratification of patients recruited to trials of therapy for low-risk gestational trophoblastic tumor. ( 10926786 )
2000
36
Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor. ( 10366457 )
1999
37
Pregnancy outcome after treatment with etoposide (VP-16) for low-risk gestational trophoblastic tumor. ( 11240760 )
1999
38
Clinical assessment of EMA/CO induced DNA damage in peripheral blood lymphocytes of high-risk gestational trophoblastic tumor patients. ( 10376437 )
1999
39
Diagnosis and treatment of the malignant gestational trophoblastic tumor with pulmonary metastasis complicated with pulmonary tuberculosis. ( 12894897 )
1999
40
Cellular immune response levels in gestational trophoblastic tumor patients after hydatidiform mole. ( 10428348 )
1999
41
Changing face of gestational trophoblastic tumor. ( 9833623 )
1998
42
Pregnancy outcome of patients conceiving within one year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 cases. ( 11189204 )
1998
43
The role of transvaginal ultrasonography in the management of gestational trophoblastic tumor. ( 7741920 )
1995
44
Evaluation of prognostic factors and staging in gestational trophoblastic tumor. ( 7970479 )
1994
45
Brain metastases of gestational trophoblastic tumor. ( 7518516 )
1994
46
Pulmonary metastases of gestational trophoblastic tumor. Risk factors for early respiratory failure. ( 8035373 )
1994
47
Liver metastases of gestational trophoblastic tumor. ( 8380786 )
1993
48
Staging rules for gestational trophoblastic tumors and fallopian tube cancer. ( 1317647 )
1992
49
Duplex ultrasonography for persistent gestational trophoblastic tumor. ( 2008004 )
1991
50
Experience of human chorionic gonadotropin assays in gestational trophoblastic tumors. ( 1680961 )
1991

Variations for Gestational Trophoblastic Tumor

Expression for Gestational Trophoblastic Tumor

Search GEO for disease gene expression data for Gestational Trophoblastic Tumor.

Pathways for Gestational Trophoblastic Tumor

GO Terms for Gestational Trophoblastic Tumor

Sources for Gestational Trophoblastic Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....